Medicus Pharma LTD. (MDCXW) — 8-K Filings

All 8-K filings from Medicus Pharma LTD.. Browse 23 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (23)

8-K Filing — Dec 30, 2025
Medicus Pharma Ltd. Files 8-K on Agreements & Equity Sales — Dec 8, 2025 Risk: medium
Medicus Pharma Ltd. filed an 8-K on December 8, 2025, reporting on several key events. These include entering into a material definitive agreement, unregistered
Medicus Pharma Ltd. Files 8-K on Executive Changes — Dec 1, 2025 Risk: medium
Medicus Pharma Ltd. filed an 8-K on November 28, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certai
Medicus Pharma Reports Unregistered Equity Sales — Oct 17, 2025 Risk: medium
Medicus Pharma Ltd. filed an 8-K on October 17, 2025, reporting unregistered sales of equity securities. The filing details the company's principal executive of
Medicus Pharma Ltd. Files 8-K for Material Agreement — Sep 18, 2025 Risk: medium
Medicus Pharma Ltd. announced on September 17, 2025, the entry into a material definitive agreement and the creation of a direct financial obligation. The compa
Medicus Pharma Ltd. Reports Board and Officer Changes — Sep 12, 2025 Risk: medium
Medicus Pharma Ltd. announced on September 12, 2025, changes in its board and officer composition, including the departure of certain directors and officers, th
Medicus Pharma Completes Acquisition, Appoints New Officers — Sep 2, 2025 Risk: medium
Medicus Pharma Ltd. announced on August 29, 2025, the completion of an acquisition, the departure of a director, and the appointment of new officers. The compan
Medicus Pharma Ltd. Files 8-K on Equity Sales — Aug 22, 2025 Risk: medium
Medicus Pharma Ltd. filed an 8-K on August 22, 2025, reporting unregistered sales of equity securities and other events. The filing details the company's operat
Medicus Pharma Ltd. Files 8-K — Aug 4, 2025 Risk: low
Medicus Pharma Ltd. filed an 8-K on August 4, 2025, reporting other events and financial statements. The company is incorporated in Ontario and has its principa
Medicus Pharma Ltd. Files 8-K Report — Jul 30, 2025 Risk: low
On July 29, 2025, Medicus Pharma Ltd. filed an 8-K report. The filing indicates that the company is incorporated in Ontario and has its principal executive offi
Medicus Pharma Ltd. Files 8-K with Updates — Jul 23, 2025 Risk: low
Medicus Pharma Ltd. filed an 8-K on July 23, 2025, reporting on matters submitted to a vote of security holders and other events. The filing includes financial
Medicus Pharma Ltd. Files 8-K: Material Agreement & Equity Sales — Jul 14, 2025 Risk: medium
On July 14, 2025, Medicus Pharma Ltd. filed an 8-K report detailing a material definitive agreement. The filing also covers unregistered sales of equity securit
Medicus Pharma Ltd. Files 8-K for Material Agreement — Jun 30, 2025 Risk: medium
On June 29, 2025, Medicus Pharma Ltd. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial stateme
Medicus Pharma Ltd. Files 8-K: Director & Officer Changes — Jun 23, 2025 Risk: medium
On June 23, 2025, Medicus Pharma Ltd. filed an 8-K report detailing changes in its board of directors and executive officers, along with updates on compensatory
Medicus Pharma Ltd. Files 8-K for Material Agreement — Jun 20, 2025 Risk: medium
On June 17, 2025, Medicus Pharma Ltd. entered into a material definitive agreement, creating a direct financial obligation. The company, headquartered at 300 Co
Medicus Pharma Appoints Marcum LLP as New Auditor — Jun 5, 2025 Risk: low
Medicus Pharma Ltd. announced on June 3, 2025, a change in its certifying accountant. The company has appointed Marcum LLP as its new independent registered pub
Medicus Pharma Ltd. Files 8-K for Material Agreement & Equity Sale — Jun 2, 2025 Risk: medium
Medicus Pharma Ltd. announced on May 29, 2025, the entry into a material definitive agreement and unregistered sales of equity securities. The company is involv
Medicus Pharma Ltd. Files 8-K for Material Agreement — May 5, 2025 Risk: medium
Medicus Pharma Ltd. announced on May 2, 2025, that it entered into a material definitive agreement. This filing also indicates the creation of a direct financia
Medicus Pharma Ltd. Files 8-K — Apr 28, 2025 Risk: low
Medicus Pharma Ltd. filed an 8-K on April 28, 2025, reporting other events and financial statements as of April 26, 2025. The company, incorporated in Ontario w
Medicus Pharma Ltd. Files 8-K — Mar 25, 2025 Risk: low
Medicus Pharma Ltd. filed an 8-K on March 25, 2025, reporting other events and financial statements as of March 21, 2025. The company, incorporated in Ontario w
Medicus Pharma Ltd. Files 8-K — Mar 20, 2025 Risk: low
Medicus Pharma Ltd. filed an 8-K on March 20, 2025, reporting other events and financial statements as of March 18, 2025. The company, incorporated in Ontario w
Medicus Pharma Ltd. Files 8-K: Material Agreement & Equity Sales — Mar 11, 2025 Risk: medium
Medicus Pharma Ltd. announced on March 6, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity
Medicus Pharma Ltd. Files 8-K: Material Agreement & Equity Sales — Feb 11, 2025 Risk: medium
On February 10, 2025, Medicus Pharma Ltd. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX